BioSkryb Genomics
PrivateLast Round
Series A
May 1, 2025
Total Funding Raised
$31.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioSkryb Genomics is a biotechnology company that develops a genome amplification system leveraging cellular heterogeneity to provide scientists and clinicians with comprehensive insights into the genome, transcriptome, and proteome of individual cells for the study of complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSkryb Genomics Comparables
Compare BioSkryb Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mission Bio | 83% | |
| Xingeyuan Biotechnology | 79% | |
| Atrandi Biosciences | 79% | |
BioSkryb Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2025 | ||||
| Seed | Jan 9, 2020 |
Key People
Founding team and executive leadership
BioSkryb Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anzu Partners | Series A, Seed |
| Wilson Sonsini Goodrich & Rosati | Seed, Series A |
| Seed Healthcare | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 42% MoM, reaching 7.7K.
- Jul 28, 2026
Monthly visitors increased 37% MoM.
BioSkryb Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioSkryb Genomics's valuation, stock price, and market status.